Stay updated on Branaplam Safety in Early Huntington's Disease Clinical Trial

Sign up to get notified when there's something new on the Branaplam Safety in Early Huntington's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Branaplam Safety in Early Huntington's Disease Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T17:44:40.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, replacing Revision: v3.4.1. This is a metadata update and does not modify core content or features.
    Difference
    0.0%
    Check dated 2026-02-13T01:32:20.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Publications section updated: added the final Nat Med 2026 paper citation and revision 3.4.1, and removed the online-ahead-of-print citation (revision 3.4.0).
    Difference
    0.1%
    Check dated 2026-02-05T12:54:52.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Show glossary option added; metadata label changed to 'Last Update Submitted that Met QC Criteria' with a new 'Revision: v3.4.0', and 'No FEAR Act Data' note updated; older labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4') were removed.
    Difference
    0.2%
    Check dated 2026-01-29T06:17:08.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    A minor metadata update shows revision v3.3.4 added and v3.3.3 removed; it does not alter study information, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T02:45:55.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Added a new publication citation under Publications: Borowsky B, Ramos H, Caputo A, Hartmann A, Faller T, Peters T, Sui Y, Liu F, Meadowcroft M, David OJ, Laisney M, Kinhikar A, Marder KS, Tabrizi SJ, Landwehrmeyer GB, Leavitt BR. Oral splicing modulator branaplam in Huntington's disease: a phase 2 randomized controlled trial. Nat Med. 2026 Jan 5.
    Difference
    0.0%
    Check dated 2026-01-08T01:32:53.000Z thumbnail image

Stay in the know with updates to Branaplam Safety in Early Huntington's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Branaplam Safety in Early Huntington's Disease Clinical Trial page.